Beri Ridgeway, MD

Appointed
2017

Education & Fellowships

Fellowship - Cleveland Clinic
Female Pelvic Medicine/Reconstructive Surgery
Cleveland, OH
2009

Residency - University of California San Diego Medical Center
OB/GYN
San Diego, CA
2006

Internship - University of California San Diego Medical Center
OB/GYN
San Diego, CA
2003

Medical Education - University of California-San Francisco School of Medicine
San Francisco, CA
2002

Undergraduate - University of California-San Diego
Psychology
La Jolla, CA
1996

Residency - University of California San Diego Medical Center
OB-GYN
San Diego, CA

Additional Training

• Robotic Surgery, console surgeon training, da Vinci Surgical System, 2007
• Program Director Certificate, 2015

Certifications

• Obstetrics and Gynecology
• Obstetrics and Gynecology - Female Pelvic Medicine and Reconstructive Surgery

Specialty Interests

urogynecology and pelvic reconstructive surgery, advanced laparoscopic surgery, robotic-assisted laparoscopy, pelvic organ prolapse, urinary incontinence, fecal incontinence, voiding dysfunction, combined urogynecologic and colorectal disorders

Awards & Honors

• Best Clinical Paper, AUGS Scientific Meeting, 2018, “A randomized controlled trial comparing combined midurethral sling and behavioral/pelvic floor therapy to midurethral sling alone for mixed urinary incontinence – the ESTEEM trial” (co-author)
• AAOGF Henry L. Darner Travel Award, American Assoc of OB-GYN Foundation, 2018
• Master Surgeon Presentation, American Urogynecologic Society, 2017
• Highest Impact Paper Award, Society of Gynecologic Surgeons and AJOG, 2017, “Perioperative adverse events after minimally invasive abdominal sacrocolpopexy” (senior author)
  InnoCentive Program Problem Proposal Selection, Cleveland Clinic, 2014
• Enterprise-wide Recognition for Clinical Care, Cleveland Clinic, 2014
• Best Paper Winner, Basic Science, AUGS/IUGA Scientific Meeting, 2014, “Urgency Urinary Incontinence Genome Wide Association Study” (co-author)
• Leadership Program Participant, American Urogynecologic Society, 2013-15
• Best Doctors in Cleveland, Cleveland Magazine, 2013, 2014
• Office of Professional Staff Affairs Leadership Rotation, Cleveland Clinic, 2013
• FLEX Professional Development Award, Case Western Reserve University, 2012-13
• President’s Award (2nd Place), SGS, 2010, “Comparison of responsiveness of validated outcome measures after surgery for stress urinary incontinence” (co-author)
  Ephraim McDowell Junior Fellow Award, ACOG, 2009, “Vulvodynia in Identical Twins: Correlation and Risk Factors” (co-author)
• First Prize for Technical Achievement in Video, ASRM, 2008
• Dr. Marinoff Vulvodynia Career Development Award, National Vulvodynia Association, 2008
• Outstanding Resident Laparoendoscopic Surgeon, SLS/UCSD, 2006
• Administrative Chief Resident, UCSD, 2005 - 2006
• Hospital-wide Outstanding House Officer, Dept. Nominee, UCSD, 2005, 2006
• Third Year Resident Research Award, UCSD, 2005
• American Urogynecologic Society, Eli Lilly Scholar, 2004
• Outstanding Graduate, Class of 2002, UCSF, 2002
• Alpha Omega Alpha, UCSF, Elected 2001

See publications for Beri Ridgeway, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/16/2024, Dr. Ridgeway has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Equity Dr. Ridgeway owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

• Ina Labs

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.